Navigation Links
HLTH Corporation Sells its Minority Interest in Emdeon Business Services to General Atlantic and Hellman & Friedman for $575 Million
Date:2/11/2008

ELMWOOD PARK, N.J., Feb. 11 /PRNewswire-FirstCall/ -- HLTH Corporation (Nasdaq: HLTH) today announced that it has completed the sale, for $575 million in cash, of its 48% minority interest in Emdeon Business Services to General Atlantic LLC and Hellman & Friedman LLC. General Atlantic previously acquired a 52% majority interest in Emdeon Business Services from HLTH in November 2006.

Martin J. Wygod, Chairman and Acting CEO of HLTH, said: "HLTH is very pleased to complete the sale of its minority interest in Emdeon Business Services to General Atlantic and Hellman & Friedman. We have worked closely with General Atlantic over the past year to further solidify Emdeon Business Services' market leadership. HLTH and WebMD look forward to continuing to work with Emdeon in our ongoing product development and marketing relationships."

In the November 2006 transaction, HLTH received approximately $1.2 billion in cash and retained a 48% interest in Emdeon Business Services. As a result of the completion of the sale of that 48% interest, HLTH has received total proceeds of approximately $1.775 billion in cash for Emdeon Business Services.

About HLTH

HLTH Corporation's (NASDAQ: HLTH) businesses are comprised of WebMD Health Corp., (NASDAQ: WBMD), ViPS and Porex. WebMD provides health information services for consumers, physicians, healthcare professionals, employers and health plans through its public and private online portals and health-focused publications. ViPS provides healthcare data management, analytics, decision- support and process automation solutions and related information technology services to governmental, Blue Cross Blue Shield and commercial healthcare payers. ViPS' solutions and services help its clients improve patient outcomes, increase customer satisfaction and reduce costs. Porex is a developer, manufacturer and distributor of proprietary porous plastic products and components used in healthcare, industrial and consumer applications.

All statements contained in this press release, other than statements of historical fact, are forward-looking statements, including those regarding our expectations concerning market opportunities and our ability to capitalize on them; the benefits expected from the transactions referred to in this press release, from new products or services and from other potential sources of additional revenue. These statements speak only as of the date of this press release and are based on our current plans and expectations, and they involve risks and uncertainties that could cause actual future events or results to be different than those described in or implied by such forward-looking statements. These risks and uncertainties include those relating to: market acceptance of our products and services; length of sales and implementation cycles for our products and services; our relationships with customers and strategic partners; changes in economic, political or regulatory conditions or other trends affecting the healthcare, Internet, information technology and plastics industries; and our ability to attract and retain qualified personnel. Further information about these matters can be found in our Securities and Exchange Commission filings. Except as required by applicable law or regulation, we do not undertake any obligation to update our forward- looking statements to reflect future events or circumstances.

WebMD(R), WebMD Health(R), POREX(R) and ViPSSM are trademarks of HLTH Corporation or its subsidiaries.

Emdeon(tm) and Emdeon Business Services(tm) are trademarks of Emdeon Business Services, LLC or its subsidiaries.


'/>"/>
SOURCE HLTH Corporation
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Triple-S Management Corporation Reports Record Consolidated Operating Income, Net Income and EPS for 2007
2. Torchmark Corporation to Present at Merrill Lynch Insurance Investors Conference
3. MedCath Corporation Reports First Quarter Earnings
4. Otter Tail Corporation Reports Record Revenues and Net Income From Continuing Operations for 2007; Earnings Per Share of $1.78; Board Approves Dividend Increase
5. STERIS Corporation Promotes Timothy L. Chapman to Group President of Healthcare
6. Volcano Corporation Selects Xactly to Drive Strategic Sales Performance Management
7. CRH Medical Corporation announces substantial increase in patient visits
8. Medical Simulation Corporation and the American Board of Internal Medicine Introduce New Simulation for Physician Assessment and Evaluation
9. Providence Service Corporation to Present at the 2008 UBS Global Healthcare Services Conference on February 11
10. Triple-S Management Corporation to Present at UBS Global Healthcare Conference
11. Mirixa Corporation Announces Leadership Change
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/21/2017)... ... January 21, 2017 , ... Pacifica Graduate ... the electrifying line-up of events for its annual meeting “Coming Home 2017,” an ... “Coming Home 2017” will be held on Friday January 27 through Sunday, ...
(Date:1/21/2017)... ... 21, 2017 , ... The Nobel Biocare™ dental implant company ... for its creos™ line of bone regenerative products. Specifically, the Nobel ... utilizes creos™ allo.gain™ bone graft for a variety of bone reconstruction procedures. In ...
(Date:1/20/2017)... ... 2017 , ... Source Vitál Apothecary, a skin and body care company dedicated ... company had a successful visit to the 2017 ECRM Diet, Vitamin & Sports Nutrition ... in the nutritional, sports and health industries a chance to meet in private sessions ...
(Date:1/20/2017)... FL (PRWEB) , ... January 20, 2017 , ... ... and wellness products to enhance people’s everyday lives, recently attended the January ECRM ... buyers. , ATP Science is known for its large range of supplements that ...
(Date:1/20/2017)... ... January 20, 2017 , ... Vitamin Well has launched ... The drinks have been produced in collaboration with Zlatan Ibrahimovic and have been ... , After a successful launch in Sweden last year, the next generation sports ...
Breaking Medicine News(10 mins):
(Date:1/19/2017)... 19, 2017 Shire plc (LSE: ... U.S. Food and Drug Administration (FDA) has acknowledged receipt ... Application (NDA) for SHP465, a long-acting, triple-bead, mixed amphetamine ... once-daily treatment for Attention-Deficit/Hyperactivity Disorder (ADHD). The FDA is ... 20, 2017, the designated Prescription Drug User Fee Act ...
(Date:1/19/2017)... 19, 2017 Pfizer joins ... Milner Therapeutics Consortium   Major research ... Cambridge   The Milner Therapeutics ... ) as a partner to the Milner Therapeutics Consortium. ... the efficient transfer of materials between industry and academia ...
(Date:1/19/2017)... Florida , January 19, 2017 ... Trump administration appears serious about reducing the FDA,s ... and innovation in the medical drug industry, many ... ahead with new clinical trials and development of ... companies forging ahead with recent developments include:  Moleculin ...
Breaking Medicine Technology: